Session Information
-
WCLC 2022
2022 World Conference on Lung Cancer
Conference Program for 2022 the World Conference on Lung Cancer
Presentation Date(s):- August 6 - 9, 2022
- Total Presentations: 2137
All times listed are in Vienna, Austria Time, CEST (UTC+2:00)
PL - Plenary
IBS - Interactive Breakfast Session (in-person attendees only)
ES - Education Session
OA - Oral Session
MA - Mini Oral Session
P - Posters
EP - ePosters
WS - Workshops
LA – Lectureship Awards
IS - Industry Symposium
August 5 Fri
Aug 5 Saturday
August 6 Sat
Aug 6 Sunday
August 7 Sun
Aug 7 Monday
August 8 Mon
Aug 8 Tuesday
August 9 Tue
Aug 9
-
+
WS08 - Joint IASLC-CSCO-CAALC Session: Liquid Biopsy in Oncogene Driven NSCLC (On-demand)
- 21:00 - 23:59
- 8/06/2022
- Location: On-Demand
- Not for CME Credit
- Type: Workshop
- Track: N/A
- Moderators:Yi-Long Wu, Chunxue Bai, Caicun Zhou, Karen Kelly
-
+
Session Moderator
21:00 - 21:00 | Presenter: Yi-Long Wu
- Abstract
Loading... -
+
Session Moderator
21:00 - 21:00 | Presenter: Chunxue Bai
- Abstract
Loading... -
+
Session Moderator
21:00 - 21:00 | Presenter: Caicun Zhou
- Abstract
Loading... -
+
Session Moderator
21:00 - 21:00 | Presenter: Karen Kelly
- Abstract
Loading... -
+
WS08.01 - Session Introduction
21:00 - 21:02 | Presenter: Yi-Long Wu
- Abstract
Loading... -
+
WS08.02 - Session Introduction
21:02 - 21:04 | Presenter: Chunxue Bai
- Abstract
Loading... -
+
WS08.03 - Session Introduction
21:04 - 21:07 | Presenter: Caicun Zhou
- Abstract
Loading... -
+
WS08.04 - Session Introduction
21:07 - 21:10 | Presenter: Karen Kelly
- Abstract
Loading... -
+
WS08.05 - Minimal Residual Disease (MRD) Negative: Potential for Cure in Resected Oncogene Driven NSCLC? Chinese Perspective
21:10 - 21:30 | Presenter: Jia-Tao Zhang
- Abstract
Loading... -
+
WS08.06 - Could MRD Change Our Clinical Practice? North American Perspective
21:30 - 21:50 | Presenter: Aadel Chaudhuri
- Abstract
Loading... -
+
WS08.07 - How to Use Liquid Biopsy to Monitor Treatment Efficacy for Advanced Driven NSCLC
21:50 - 22:10 | Presenter: Jie Hu
- Abstract
Loading... -
+
WS08.08 - Liquid Biopsy for Advanced Oncogene Driven NSCLC. European Perspective
22:10 - 22:30 | Presenter: Martin Filipits
- Abstract
Loading... -
+
WS08.09 - Sintilimab versus Pembrolizumab as Monotherapy or in Combination with Chemotherapy for Treatment Naïve Metastatic Non-small Cell Lung Cancer
22:30 - 22:40 | Presenter: Si-Yang Maggie Liu | Author(s): Qing Zhou, Hong-Hong Yan, Bin Gan, Ming-Yi Yang, Jia-Ying Deng, Hai-Yan Tu, Xu-chao Zhang, Jian Su, Jin-Ji Yang, Yi-Long Wu
- Abstract
Loading... -
+
WS08.10 - Toripalimab in Combination with CIK Cells in Patients with Advanced NSCLC: An Exploratory Study
22:40 - 22:50 | Presenter: Xuxinyi Ling | Author(s): Baohui Han, Runbo Zhong
- Abstract
Loading... -
+
WS08.11 - Entrectinib in Patients with ROS1 Fusion-Positive (ROS1-fp) NSCLC: Updated Efficacy and Safety Analysis
22:50 - 23:00 | Presenter: Yun Fan | Author(s): Alexander Drilon, Chao-Hua Chiu, Daniel W. Bowles, Herbert H.F. Loong, Salvatore Siena, Koichi Goto, Maciej Krzakowski, Myung-Ju Ahn, Haruyasu Murakami, Rafal Dziadziuszko, Harald Zeuner, Bethany Pitcher, Diarra Cheick, Matthew G. Krebs
- Abstract
This abstract is currently under embargo and will be released during the conference.
-
+
WS08.12 - Discussant for Oral Abstracts
23:00 - 23:20 | Presenter: Sai-Hong Ignatius Ou
- Abstract
Loading... -
+
WS08.13 - Activity of aPD1-MSLN-CART Cells Against Metastatic Lung Cancer in a Phase 1 Trial
23:20 - 23:21 | Presenter: Xiaorong Dong | Author(s): Lingjuan Chen, Lu Wen, Ling Peng, Fan Tong
- Abstract
Loading... -
+
WS08.14 - Final Analyses of ALTER-L018: A Randomized Phase II Trial of Anlotinib Plus Docetaxel vs Docetaxel as 2nd-line Therapy for EGFR-Negative NSCLC
23:21 - 23:22 | Presenter: Lin Wu | Author(s): Zhijun Wu, Zemin Xiao, Zhongxia Ma, Jie Weng, Yanhua Chen, Yongqing Cao, Peiguo Cao, Maoliang Xiao, Hui Zhang, Huaxin Duan, Qianzhi Wang, Jia Li, Yan Xu, Xingxiang Pu, Kang Li
- Abstract
Loading... -
+
WS08.15 - Safety and Efficacy of Sitravatinib + Tislelizumab in Patients with PD-L1+, Locally Advanced/Metastatic, Squamous NSCLC
23:22 - 23:23 | Presenter: Jun Zhao | Author(s): Jiuwei Cui, DingZhi Huang, Meili Sun, Zhiyong Ma, Qian Chu, Yunpeng Liu, Zhehai Wang, Xin Li, Hui Li, Juan Zhang, Jingchao Sun, Cong Fei, Yi-Long Wu
- Abstract
Loading... -
+
WS08.16 - The Increase of Blood Intratumor Heterogeneity is Associated with Unfavorable Outcomes of ICIs Plus Chemotherapy in NSCLC
23:23 - 23:24 | Presenter: Juan Zhou | Author(s): Minwei Bao, Guanghui Gao, Yiran Cai, Lihong Wu, Lei Lei, Jing Zhao, Xianxiu Ji, Ying Huang, Chunxia Su
- Abstract
Loading... -
+
WS08.17 - Utilization of Tumor Mutational Profiling to Identify the Immunotherapy Response in Non-small Cell Lung Cancer
23:24 - 23:25 | Presenter: Wenbin Li | Author(s): Peng Song, Xiaoxuan Wu, Xinying Shi, Weiwei Tian, Zhihua Pei, Dongliang Wang, Shugeng Gao
- Abstract
Loading... -
+
WS08.18 - Discussant for Poster 1 - 5
23:25 - 23:40 | Presenter: Xiaorong Dong
- Abstract
Loading... -
+
WS08.19 - Phase Il Trial of Neoadjuvant Tislelizumab with Chemotherapy for Resectable Stage IIB-III Non-small Cell Lung Cancer
23:40 - 23:41 | Presenter: Yao-Bin Lin | Author(s): Hao Long, You-Hao Chen, Wen-Yu Zhai, Yi-Zhi Wang, Bing-Yu Rao
- Abstract
Loading... -
+
WS08.20 - Comprehensive Analysis of a Dendritic Cell Marker Genes Signature to Predict Prognosis and Immunotherapy Response in Lung Adenocarcinoma
23:41 - 23:42 | Presenter: Yuan Li | Author(s): Peng Song, Fenglong Bie, Moyan Zhang, Shugeng Gao, Jie He
- Abstract
Loading... -
+
WS08.21 - Immune Evolution of Metastases & Underlying Molecular Mechanisms in Non-small Cell Lung Cancer
23:42 - 23:43 | Presenter: Wen-Fang Tang | Author(s): Rui Fu, xiaojun fan, Hua Bao, Min Wu, Xue Wu, Yang Shao, Zhen-bin Qiu, Jian Su, Yi-Long Wu, Yi Liang, Wenzhao Zhong
- Abstract
Loading... -
+
WS08.22 - Neoadjuvant Toripalimab Combination in Patients with Stage IIB-IIIB NSCLC: A Single-arm, Phase 2 Trial (Renaissance Study)
23:43 - 23:44 | Presenter: Shi Yan | Author(s): Jinfeng Chen, Jia Wang, Chao Li, Jiwang Bi, Xin Yang, Shaolei Li, Yuzhao Wang, Xiang Li, Yue Yang, Nan Wu
- Abstract
Loading... -
+
WS08.23 - Transcriptomic Heterogeneity in Non-Small Cell Lung Cancer with Four Structure-Based EGFR-Mutation Subgroups
23:44 - 23:45 | Presenter: Shun Lu | Author(s): LinPing Gu, Yongfeng Yu, Lan Shen, Fei Yao, Changbin Zhu, Jin Wang
- Abstract
Loading... -
+
WS08.24 - Discussant for Poster 6 - 10
23:35 - 23:50 | Presenter: Ming Fang Zhao
- Abstract
Loading...
-
+
ES05 - Oncogenic Alterations and Beyond - Novel Treatments
- 12:00 - 13:00
- 8/07/2022
- Location: Hall C2
- IASLC CME Accredited
- Type: Education Session
- Track: Metastatic Non-small Cell Lung Cancer - Molecular Targeted Treatments
- Moderators:Caicun Zhou, Maximilian Johannes Hochmair
-
+
Session Moderator
12:00 - 12:00 | Presenter: Caicun Zhou
- Abstract
Loading... -
+
Session Moderator
12:00 - 12:00 | Presenter: Maximilian Johannes Hochmair
- Abstract
Loading... -
+
ES05.01 - Session Introduction
12:00 - 12:01 | Presenter: Caicun Zhou
- Abstract
Loading... -
+
ES05.02 - Session Introduction
12:01 - 12:02 | Presenter: Maximilian Johannes Hochmair
- Abstract
Loading... -
+
ES05.03 - Targeting Rarer Events in Known Targets: EGFR Exon20 (EGFR, HER2)
12:02 - 12:14 | Presenter: Giannis Mountzios
- Abstract
Loading... -
+
ES05.04 - All You Need to Know About KRAS
12:14 - 12:26 | Presenter: Odd Terje Brustugun
- Abstract
Loading... -
+
ES05.05 - Antibody-Drug Conjugates - Where We Stand Today?
12:26 - 12:38 | Presenter: Bob T. Li
- Abstract
Loading... -
+
ES05.06 - HRD/DDR in Lung Cancer: Role and Therapeutic Implications
12:38 - 12:50 | Presenter: Lauren Averett Byers
- Abstract
Loading... -
+
ES05.07 - Live Q&A
12:50 - 13:00
- Abstract
Loading...
-
+
EP05.02 - Locally Advanced Non-small Cell Lung Cancer - Neoadjuvant and Adjuvant Therapy
- 09:45 - 18:00
- 8/07/2022
- Location: Exhibit Hall - Hall B
- Not for CME Credit
- Type: E-Poster
- Track: Locally Advanced Non-small Cell Lung Cancer - Neoadjuvant and Adjuvant Therapy
-
+
EP05.02-021 - An Updated Analysis of Toripalimab and Platinum-Doublet Chemotherapy as Neoadjuvant Therapy for Potentially Resectable NSCLC
Presenter: Yongchang Zhang | Author(s): Liang Zeng, Xiangyu Zhang, Yuling Zhou, Baihua Zhang, Lin Guo, Wenjuan Jiang, Yi Xiong, Haiyan Yang, Li Liu, Tao Jiang, Caicun Zhou, Nong Yang- Abstract
Loading...
-
+
EP08.01 - Metastatic Non-small Cell Lung Cancer - Immunotherapy
- 09:45 - 18:00
- 8/07/2022
- Location: Exhibit Hall - Hall B
- Not for CME Credit
- Type: E-Poster
- Track: Metastatic Non-small Cell Lung Cancer - Immunotherapy
-
+
EP08.01-014 - Tislelizumab versus Docetaxel in Previously Treated Advanced Non-Small Cell Lung Cancer: Final Analysis of RATIONALE-303
Presenter: Caicun Zhou | Author(s): DingZhi Huang, Yun Fan, Xinmin Yu, Yunpeng Liu, Yongqian Shu, Zhiyong Ma, Ziping Wang, Ying Cheng, Jie Wang, Sheng Hu, Zhihua Liu, Elena Poddubskaya, Umut Disel, Andrey Akopov, Mikhail Dvorkin, Yan Wang, Songzi Li, Cunjing Yu, Gareth Rivalland- Abstract
Loading... -
+
EP08.01-035 - Personalized ctDNA Detection to Monitor Outcome and Predict Immunotherapy Benefit in Locally Advanced and Metastatic NSCLC
Presenter: Guanghui Gao | Author(s): Lei Cheng, Chao Zhao, Xuefei Li, Chao Yao, Feng Li, Dong You, Caicun Zhou- Abstract
Loading...
-
+
EP08.02 - Metastatic Non-small Cell Lung Cancer - Molecular Targeted Treatments
- 09:45 - 18:00
- 8/07/2022
- Location: Exhibit Hall - Hall B
- Not for CME Credit
- Type: E-Poster
- Track: Metastatic Non-small Cell Lung Cancer - Molecular Targeted Treatments
-
+
EP08.02-064 - ASTRIS China: A Real-world Study of Osimertinib in Patients with EGFR T790M Positive Non-small-cell Lung Cancer (NSCLC)
Presenter: Qing Zhou | Author(s): He-Long Zhang, Li-Yan Jiang, Yuankai Shi, Yuan Chen, Jin-Ming Yu, Caicun Zhou, Yong He, Yan-Ping Hu, Zong-An Liang, Yue-Yin Pan, Wen-Lei Zhuo, Yong Song, Gang Wu, Gong-Yan Chen, You Lu, Cui-Ying Zhang, Yi-Ping Zhang, Ying Chen, Shun Lu, Yi-Long Wu- Abstract
Loading... -
+
EP08.02-171 - PRO-CTCAE Analysis of Mobocertinib in EGFR Exon 20 Insertion‒Positive Metastatic Non‒Small Cell Lung Cancer (NSCLC)
Presenter: Rosario Garcia | Author(s): Caicun Zhou, Suresh S. Ramalingam, Huamao Mark Lin, Tae Min Kim, Gregory J Riely, Tarek Mekhail, Danny Nguyen, Joshua Biber, Heather Romero, Erin Goodman, Sanjay Popat, Pasi A Janne- Abstract
Loading...
-
+
EP16.01 - Tumor Biology and Biomarkers - Immune Biology & Immunotherapy
- 09:45 - 18:00
- 8/07/2022
- Location: Exhibit Hall - Hall B
- Not for CME Credit
- Type: E-Poster
- Track: Tumor Biology and Biomarkers - Immune Biology & Immunotherapy
-
+
EP16.01-005 - Cilia-related mRNA Profile Predicts Clinical Response to PD-1 Blockade in Lung Adenocarcinoma
Presenter: Guanghui Gao | Author(s): Tao Jiang, Fei Zhou, Fengying Wu, Wei Li, Anwen Xiong, Xiaoxia Chen, Shengxiang Ren, Chunxia Su, Tao Hu, Qian Li, Changbin Zhu, Caicun Zhou- Abstract
Loading...
-
+
PL03 - Plenary 3: Presidential Symposium - Top Rated Abstracts (Live Streamed Session)
- 08:30 - 10:20
- 8/08/2022
- Location: Hall C1
- IASLC CME Accredited
- Type: Plenary
- Track: N/A
- Moderators:Heather Wakelee, Eric Lim
-
+
PL03.09 - IMpower010:Overall Survival Interim Analysis of a Phase III Study of Atezolizumab vs Best Supportive Care in Resected NSCLC
Presenter: ENRIQUETA FELIP | Author(s): Heather Wakelee, Nasser Khaled Altorki, Eric Vallieres, Ihor O. Vynnychenko, Andrey Akopov, Alex Martinez-Marti, Antonio Chella, Igor Bondarenko, Sunichi Sugawara, Yun Fan, Hirotsugu Kenmotsu, Yuh-Min Chen, Yu Deng, Fan Wu, Virginia McNally, Elizabeth Bennett, Barbara Gitlitz, Caicun Zhou- Abstract
Loading...
